News

International Petroleum Corporation Shares Buyback Update

International Petroleum Corporation Shares Buyback Update

International Petroleum Corporation Shares Buyback Results

International Petroleum Corporation (IPC) has made an announcement regarding their share buyback following its normal course issuer bid (NCIB) plan. This move showcases IPC's dedicated effort to boost shareholder value. From September 16 to 20, the company successfully repurchased a total of 190,600 IPC common shares, indicating solid activity in its stock management approach.

Buyback Program Details

IPC launched its NCIB on December 1, 2023. This program aligns with financial regulations as well as market practices in both Canada and Sweden. The share repurchase initiative complies with the guidelines established by the Toronto Stock Exchange (TSX) and Nasdaq Stockholm, in addition to relevant Canadian and Swedish securities regulations, ensuring everything is done transparently.

Share Repurchases on Nasdaq Stockholm

Throughout the reporting timeframe, IPC made significant shares purchases on Nasdaq Stockholm, buying back 150,000 IPC common shares via its broker, Pareto Securities AB. This activity illustrates IPC's ongoing commitment to effectively managing capital and maximizing returns for shareholders.

Share Activity on the TSX

In tandem with its efforts in Stockholm, IPC also conducted share repurchases on the TSX, securing an additional 40,600 shares through ATB Capital Markets Inc. This combined approach highlights IPC's strategic presence across both primary stock exchanges.

Consequences of the Share Buyback

All shares that IPC acquires through the NCIB will be canceled later, which will decrease the total number of outstanding shares. As of September 20, 2024, IPC had issued 121,473,438 common shares, while 613,900 shares remained held in treasury. This proactive management of shares not only enhances earnings per share but also reflects IPC's confidence in its upcoming performance.

Overview of the NCIB

Since starting the NCIB in December 2023, IPC has effectively repurchased a total of 7,365,282 shares under the program. The cap for shares to be repurchased during this twelve-month interval is set at 8,342,119, demonstrating IPC's strategic use of capital and focus on returning value to shareholders.

Market Conditions Impact

The NCIB was initiated in response to a shifting market environment. IPC's management is actively navigating the challenges posed by unpredictable commodity prices and varying economic conditions, showcasing their strong commitment to investors and aligning corporate actions with shareholder interests.

About International Petroleum Corporation

International Petroleum Corporation is engaged in oil and gas exploration and production and has a diverse asset portfolio. The corporation operates in Canada, Malaysia, and France and is a part of the Lundin Group of Companies. IPC’s shares trade on both the Toronto Stock Exchange (TSX) and Nasdaq Stockholm under the symbol "IPCO," establishing it as a noteworthy entity in the global energy sector.

Contact Information for Investor Queries

For more details regarding IPC's recent activities and their commitment to stakeholders, please reach out to:

Rebecca Gordon
SVP Corporate Planning and Investor Relations
Tel: +41 22 595 10 50

Robert Eriksson
Media Manager
Tel: +46 701 11 26 15

Frequently Asked Questions

What led IPC to start its share repurchase program?

The share repurchase program is designed to enhance shareholder value by decreasing the number of outstanding shares, which in turn can lead to an increase in earnings per share.

How many shares has IPC bought back under its NCIB?

As of September 20, 2024, IPC has repurchased a total of 7,365,282 shares as part of its normal course issuer bid program.

Who oversees the share repurchase transactions for IPC?

Pareto Securities AB manages the transactions conducted on Nasdaq Stockholm, while ATB Capital Markets Inc. handles the TSX repurchases.

Will the shares that are repurchased be canceled?

Yes, all shares bought through the NCIB will be canceled, resulting in a lower total of outstanding shares for IPC.

How does the NCIB fit into IPC’s growth strategy?

The NCIB aligns with IPC's growth strategy by optimizing how capital is allocated and enhancing shareholder value, especially during times of fluctuating market conditions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

WeightWatchers Shifts 2025 Earnings Call for Key Accounting Updates

Updated Category News Views 154

WeightWatchers Adjusts Schedule for 2025 Earnings Report WW International, Inc. (NASDAQ: WW), widely recognized for its innovative weight management solutions, has made an important change regarding its upcoming earnings report. The company has rescheduled its earnings release and associated conference call originally intended for August 5, 2025. This Rescheduling is...

Continue Reading
Investors Alert: Key Investigations into Regeneron Pharmaceuticals

Updated Category News Views 120

Investors Take Note: Faruqi & Faruqi Seeks to Help Faruqi & Faruqi, LLP, a prominent national securities litigation firm, is leading an investigation focusing on investors who may have sustained significant losses with Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). The firm encourages those who believe they have suffered losses of over $100,000 due to the company’s...

Continue Reading
Waller's Bold Critique of Powell: A Call for Rate Cuts

Updated Category News Views 233

Waller’s Challenge to Economic Caution Federal Reserve Governor Christopher Waller has made headlines by challenging the stance of Chairman Jerome Powell, particularly regarding his assertion that economic data is too sparse to draw clear conclusions. Waller believes the Fed should proceed with easing monetary policy, even amidst perceived gaps in information. Ending...

Continue Reading
Michael John Politis Recognized as Elite Attorney in America

Updated Category News Views 276

Michael John Politis Achieves National Recognition Michael John Politis, a distinguished attorney at Politis & Matovina, P.A., has garnered significant acclaim by being recognized as a member of the Nation's Top One Percent. This prestigious acknowledgment is bestowed by the National Association of Distinguished Counsel (NADC). The NADC is committed to upholding the...

Continue Reading
Home Buying Opportunities: Navigating the Market's Shift

Updated Category News Views 74

Introduction For many home buyers, fall typically signals a slow down in the housing market. But this year, things might unfold differently. With mortgage rates dropping and inventory on the rise, buyers could have a chance to find their dream homes during what is usually seen as the offseason. Affordability Improves The recent decline in monthly mortgage payments has...

Continue Reading